Literature DB >> 14695418

Systematic identification of drugs that cause birth defects--a new opportunity.

Allen A Mitchell1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14695418     DOI: 10.1056/NEJMsb031395

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

Review 1.  Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Eur J Clin Pharmacol       Date:  2011-11-13       Impact factor: 2.953

2.  Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland.

Authors:  Linda Irvine; Robert W V Flynn; Gillian Libby; Iain K Crombie; Josie M M Evans
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Are epidemiological approaches suitable to study risk/preventive factors for human birth defects?

Authors:  Sonia Hernandez-Diaz; Anna Sara Oberg
Journal:  Curr Epidemiol Rep       Date:  2015-03

Review 4.  Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.

Authors:  Fokaline Vroom; Hermien E K de Walle; Mart A J F van de Laar; Jacobus R B J Brouwers; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Medication Exposure in Pregnancy Risk Evaluation Program.

Authors:  Susan E Andrade; Robert L Davis; T Craig Cheetham; William O Cooper; De-Kun Li; Thushi Amini; Sarah J Beaton; Sascha Dublin; Tarek A Hammad; Pamala A Pawloski; Marsha A Raebel; David H Smith; Judy A Staffa; Sengwee Toh; Inna Dashevsky; Katherine Haffenreffer; Kimberly Lane; Richard Platt; Pamela E Scott
Journal:  Matern Child Health J       Date:  2012-10

Review 6.  Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.

Authors:  Rachel A Charlton; Marianne C Cunnington; Corinne S de Vries; John G Weil
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.

Authors:  Agnes Kant; Loes de Vries; Leàn Rolfes
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

9.  Maternal use of oral contraceptives and risk of hypospadias - a population-based case-control study.

Authors:  Pia Wogelius; Erzsébet Horváth-Puhó; Lars Pedersen; Mette Nørgaard; Andrew E Czeizel; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2006-11-01       Impact factor: 8.082

10.  Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Authors:  Marian K Bakker; Pieternel Kölling; Paul B van den Berg; Hermien E K de Walle; Lolkje T W de Jong van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-10-22       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.